<DOC>
	<DOCNO>NCT01450449</DOCNO>
	<brief_summary>This multi-centre prospective , non-inferiority trial . Patients randomize two treatment group 1:1 ratio stratify age , Karnofsky Performance Status extent surgical resection . This study assess effect one-week radiotherapy regimen comparison three-week radiotherapy regimen survival elderly and/or frail patient glioblastoma multiforme ( Frail : ≥ &gt; 50 year old KPS 50 % less50 % -70 % ; Elderly frail : ≥65 year KPS 50 % - 70 % ; Elderly : ≥65 year KPS 80 % - 100 % ) .</brief_summary>
	<brief_title>Short Course vs. Standard Course Radiotherapy Elderly and/or Frail Patients With Glioblastoma Multiforme</brief_title>
	<detailed_description>This multi-centre prospective , non-inferiority trial . Patients randomize two treatment group 1:1 ratio stratify : - Age ( &lt; 65 ≥65 year old ) - Karnofsky Performance Status ( ≤70 &gt; 7050 high ) - Extent resection surgery ( biopsy versus complete/near total gross total incomplete /partial resection ) Randomization : Patients randomize receive one two follow treatment : Arm 1 : - Short Radiotherapy - 25 Gy/5 fraction - 1 week ( 5 fraction per week ) Arm 2 : - Regular Radiotherapy - 40 Gy/15 fraction - 3 week ( 5 fraction per week )</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>Histopathologically confirm newly diagnose glioblastoma multiforme ( GBM , WHO grade IV ) . The histological diagnosis must make locally biopsy neurosurgical tumour resection . Initial surgery/biopsy diagnosis perform &lt; 6 week ( 42 day ) prior randomization . Patient 's age 50 year old . Karnofsky performance status 50 % high . Patients may receive continue receive corticosteroid , stable decrease dose least 14 day prior randomization . Patients must receive prior chemotherapy radiotherapy . Patient able ( i.e . sufficiently fluent ) willing complete quality life questionnaires either English language questionnaire officially translate . The baseline assessment ( prior start radiotherapy ) must already complete . Inability ( illiteracy , loss sight , equivalent reason ) complete questionnaire make patient ineligible study . In centre patient able read write , proxy interview conduct inperson via telephone nurse particular centre . Patient consent must obtain accord local institutional policy . It responsibility local participate investigator obtain necessary local clearance , indicate write IAEA Study Coordinator clearance obtain , trial commence centre . A copy initial full board ERB approval approve consent form must send Project Officer IAEA . The patient must sign consent form prior randomization registration . Patients must accessible treatment followup . Investigators must assure patient randomized trial available complete documentation treatment , adverse event , followup . Protocol treatment begin within 2 week patient randomization . Patients history malignancy , except : adequately treat nonmelanoma skin cancer , curatively treated insitu cancer cervix , solid tumour curatively treat evidence disease 3 year . Patients serious active infection serious underlie medical condition would impair ability patient receive protocol treatment comply protocol .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>GBM , fractionation , short course , standard course</keyword>
</DOC>